LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 962 | 400 | 10605 | 0.0378 | -0.0582 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 658 | 147 | 3846 | 0.0384 | -0.1601 |
MCF 10A | PF431396 | 10.0 | uM | LJP5 | 72 | hr | 962 | 413 | 10605 | 0.0389 | -0.0570 |
MCF 10A | AZD7762 | 10.0 | uM | LJP6 | 72 | hr | 962 | 414 | 10605 | 0.0391 | -0.0568 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 658 | 154 | 3846 | 0.0401 | -0.1581 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1235 | 185 | 4513 | 0.0411 | -0.3204 |
MCF7 | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 1209 | 170 | 4093 | 0.0415 | -0.3605 |
BT-20 | Mitoxantrone | 10.0 | uM | LJP5 | 72 | hr | 1097 | 158 | 3769 | 0.0419 | -0.3515 |
MCF 10A | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 962 | 452 | 10605 | 0.0426 | -0.0529 |
MCF 10A | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10605 | 0.0434 | -0.0520 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10605 | 0.0434 | -0.0520 |
MCF 10A | GSK1059615 | 10.0 | uM | LJP5 | 72 | hr | 962 | 480 | 10605 | 0.0453 | -0.0500 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1235 | 205 | 4513 | 0.0455 | -0.3144 |
MCF 10A | GSK1059615 | 10.0 | uM | LJP6 | 72 | hr | 962 | 491 | 10605 | 0.0464 | -0.0488 |
MCF 10A | Radicicol | 10.0 | uM | LJP5 | 72 | hr | 962 | 495 | 10605 | 0.0467 | -0.0484 |
Hs 578T | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 658 | 183 | 3846 | 0.0476 | -0.1491 |
MCF 10A | Mitoxantrone | 10.0 | uM | LJP5 | 72 | hr | 962 | 509 | 10605 | 0.0480 | -0.0470 |
Hs 578T | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 658 | 184 | 3846 | 0.0480 | -0.1485 |
Hs 578T | WH-4-025 | 10.0 | uM | LJP5 | 72 | hr | 658 | 186 | 3846 | 0.0484 | -0.1481 |
MCF 10A | Dasatinib | 10.0 | uM | LJP6 | 72 | hr | 962 | 514 | 10605 | 0.0485 | -0.0464 |
MCF 10A | QL-XII-47 | 10.0 | uM | LJP6 | 72 | hr | 962 | 522 | 10605 | 0.0492 | -0.0456 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 962 | 522 | 10605 | 0.0493 | -0.0456 |
MDA-MB-231 | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 234 | 4513 | 0.0518 | -0.3057 |
MCF 10A | Mitoxantrone | 10.0 | uM | LJP6 | 72 | hr | 962 | 552 | 10605 | 0.0521 | -0.0425 |
Hs 578T | AZD7762 | 10.0 | uM | LJP6 | 72 | hr | 658 | 203 | 3846 | 0.0530 | -0.1426 |